Today, the NIH PMI Cohort Program announced results from a recent survey designed to measure public attitudes about the Precision Medicine Initiative (PMI) Cohort Program. A majority of respondents were willing to participate...

Illustration by Christ-Claude Mowandza-Ndinga/UNC Health Care CHAPEL HILL, NC – Researchers at the UNC School of Medicine found that nearly 80 percent of peanut-allergic preschool children were successfully treated with...

Today, the NIH PMI Cohort Program announced results from a recent survey designed to measure public attitudes about the Precision Medicine Initiative (PMI) Cohort Program. A majority of respondents were willing to participate...

In UNC Health Care's new video series, Medicine’s Mentors, professionals and medical students share stories of those who helped shape them and discuss what makes mentorship at UNC Health Care unique. Here, Kenya McNeal-Trice,...

Zhen Gu at North Carolina State University in Raleigh, N.C. Justin Cook for STAT RALEIGH, N.C. — Last summer, a young, unheralded scientist named Zhen Gu unveiled a “smart” insulin patch, yet another in a string of biomedical...

Members of the UNC School of Medicine class of 2020 arrived on campus this week to begin their medical school journey. During their four years, they will learn in classrooms and clinics here in Chapel Hill, across the state...

The Carolinas Collaborative, which aims to support data-driven, inter-institutional clinical research and QI, is now open for business. Through Carolinas Collaborative, researchers can request patient counts or sets...

Close-up of an embryonic stem cellAnne-Christine Poujoulat/AFP/Getty Images Federal health officials said Thursday they are reconsidering a moratorium on the funding of research in which human tissues are transplanted...

(Chapel Hill, N.C. – Aug. 11, 2016) – The University of North Carolina at Chapel Hill today announced that Gary L. Bowen has been selected as the new dean for the School of Social Work. He is currently Kenan Distinguished...

Study participants may have been too sick to benefit from the medication, diabetes expert says The theory for this trial was that this drug -- from a class of medications called (GLP-1) agonists -- might interact with the...